---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-059690"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T13:26:29.545560+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# INmune Bio raises ~$19M in registered direct offering of 3M shares at $6.30/sh

## Summary
- Offering of 3,000,000 common shares at $6.30/share to two healthcare-focused institutional investors.
- Gross proceeds of approximately $19 million; net proceeds for working capital and general corporate purposes.
- A.G.P./Alliance Global Partners acted as sole placement agent; 7% cash fee paid.
- Pricing announced June 27, 2025; closing occurred June 30, 2025.
- Shares offered under effective shelf registration statement (Form S-3, File No. 333-279036).

## SEC filing metadata
- accession: 0001213900-25-059690
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/0001213900-25-059690-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/ea0247461-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-059690
- JSON: https://secwatch.observer/filing/0001213900-25-059690.json
- Plain text: https://secwatch.observer/filing/0001213900-25-059690.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.